VENNTURE-A novel Venn diagram investigational tool for multiple pharmacological dataset analysis

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Martin, Bronwen ^a   Chadwick, Wayne ^a   Yi, Tie ^a   Park, Sung Soo ^a   Lu, Daoyuan ^a   Ni, Bin ^a   Gadkaree, Shekhar ^a   Farhang, Kathleen ^a   Becker, Kevin G ^a   Maudsley, Stuart ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIGAND; METHACHOLINE CHLORIDE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DATA ANALYSIS; DATA ANALYSIS SOFTWARE; DOSE RESPONSE; ELECTRONIC SPREADSHEET; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; RELIABILITY; SIGNAL TRANSDUCTION; VENN DIAGRAM; BIOLOGY; COMPUTER PROGRAM; DRUG EFFECT; FACTUAL DATABASE; METABOLISM; PHARMACOLOGY; PHOSPHORYLATION; PROTEOMICS; STATISTICAL ANALYSIS; STATISTICS; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE;

CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIGANDS; METHACHOLINE CHLORIDE; MUSCARINIC AGONISTS; PHARMACOLOGY; PHOSPHORYLATION; PROTEOMICS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; SOFTWARE; TANDEM MASS SPECTROMETRY;

EID: 84860995833     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036911     Document Type: Article

References (50)

1. Venn J, (1880) On the Diagrammatic and Mechanical Representation of Propositions and Reasonings. Philosophical Magazine and Journal of Science 9: 1-18.
2. Edwards AWF, (1989) Venn diagrams for many sets. Bulletin of the International Statistical Institute. 1: 311-312.
3. Oliveros JC, (2007) VENNY. An interactive tool for comparing lists with Venn Diagrams. 18 Venny website: http://bioinfogp.cnb.csic.es/tools/venny/. Accessed 2012 April.
4. Hulsen T, de Vlieg J, Alkema W, (2008) BioVenn- a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 9: 488.
5. Pirooznia M, Nagarajan V, Deng Y, (2007) GeneVenn - A web application for comparing gene lists using Venn diagrams. Bioinformation 1: 420-422.
6. Kestler HA, Müller A, Kraus JM, Buchholz M, Gress TM, et al. (2008) VennMaster: area-proportional Euler diagrams for functional GO analysis of microarrays. BMC Bioinformatics 9: 67.
7. Maudsley S, Martin B, Luttrell LM, (2007) G protein-coupled receptor signaling complexity in neuronal tissue: implications for novel therapeutics. Curr Alzheimer Res 4: 3-19.
8. Maudsley S, Martin B, Luttrell LM, (2005) The origins of diversity and specificity in G protein-coupled receptor signaling. J Pharmacol Exp Ther 314: 485-494.
9. Luttrell LM, (2005) Composition and function of G protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity. J Mol Neurosci 26: 253-264.
10. Luttrell LM, Ferguson SSG, Daaka Y, Miller WE, Maudsley S, et al. (1999) β-Arrestin-dependent formation of β2 adrenergic receptor/Src protein kinase complexes. Science 283: 655-661.
11. Maudsley S, Liao S, Yuan L, Lefkowitz RJ, Luttrell LM, et al. (2010) The unique efficacy profile of a β-Arrestin pathway-selective parathyroid hormone receptor agonist revealed by metabolic pathways analysis. Endocr Rev 31: 142.
12. Chadwick WA, Maudsley S, (2009) The Devil Is in the Dose: Complexity of Receptor Systems and Responses. In Hormesis: A Revolution in Biology, Toxicology and Medicine. Springer-Verlag New York, 95.
13. Martin B, Brenneman R, Golden E, Walent T, Becker KG, et al. (2009) Growth factor signals in neural cells: coherent patterns of interaction control multiple levels of molecular and phenotypic responses. J Biol Chem 284: 2493-2511.
14. Chadwick W, Zhou Y, Park SS, Wang L, Mitchell N, et al. (2010) Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses," PLoS One 5: e14352.
15. Maudsley S, Davidson L, Pawson AJ, Chan R, López de Maturana R, et al. (2004) Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor. Cancer Res 64: 7533-7544.
16. Brink CB, Harvey BH, Bodenstein J, Venter DP, Oliver DW, (2004) Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology. Br J Clin Pharmacol 57: 373-387.
17. Davidson L, Pawson AJ, López de Maturana R, Freestone SH, Barran P, et al. (2004) Gonadotropin-releasing hormone-induced activation of diacylglycerol kinase-zeta and its association with active c-src. J Biol Chem 279: 11906-11916.
18. Gatlin CL, Kleemann GR, Hays LG, Link AJ, Yates JR, 3rd, (1998) Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry. Anal Biochem 263: 93-101.
19. Nühse T, Yu K, Salomon A, (2007) Isolation of phosphopeptides by immobilized metal ion affinity chromatography. Curr Protoc Mol Biol 18: 1-23.
20. Elias JE, Gygi SP, (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 4: 207-214.
21. Nichols AM, White FM, (2009) Manual validation of peptide sequence and sites of tyrosine phosphorylation from MS/MS spectra. Methods Mol Biol 492: 143-160.
22. Park SS, Maudsley S, (2011) Discontinuous pH gradient-mediated separation of TiO2-enriched phosphopeptides. Anal Biochem 409: 81-88.
23. López de Maturana R, Pawson AJ, Lu ZL, Davidson L, Maudsley S, et al. (2008) Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling. Mol Endocrinol 22: 1711-1722.
24. Perez DM, Hwa J, Gaivin R, Mathur M, Brown F, et al. (1996) Constitutive activation of a single effector pathway: Evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol 49: 112-122.
25. Krumins AM, Barber R, (1997) The stability of the agonist β 2-adrenergic receptor-Gs complex: evidence for agonist-specific states. Mol Pharmacol 52: 144-154.
26. Scaramellini C, Leff P, (1998) A three-state receptor model: predictions of multiple agonist pharmacology for the same receptor type," Ann N Y Acad Sci 861: 97-103.
27. Zhang B, Kirov SA, Snoddy JR, (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: 741-748.
28. Duncan DT, Prodduturi N, Zhang B, (2010) WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics 11: 10.
29. Wang L, Martin B, Brenneman R, Luttrell LM, Maudsley S, (2009) Allosteric modulators of G protein-coupled receptors: future therapeutics for complex physiological disorders. J Pharmacol Exp Ther 331: 340-348.
30. Gesty-Palmer D, Luttrell LM, (2008) Heptahelical terpsichory. Who calls the tune? J Recept Signal Transduct Res 28: 39-58.
31. De Lean A, Stadel JM, Lefkowitz RJ, (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255: 7108-7117.
32. Samama P, Cotecchia S, Costa T, Lefkowitz RJ, (1993) A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268: 4625-4636.
33. Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, et al. (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54: 94-104.
34. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, et al. (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365: 170-175.
35. Meller E, Puza T, Diamond J, Lieu HD, Bohmaker K, (1992) Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro. J Pharmacol Exp Ther 263 462-469, 1992.
36. Maudsley S, Pierce KL, Zamah AM, Miller WE, Ahn S, et al. (2000) The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 275: 9572-9580.
37. Hall RA, Premont RT, Chow CW, Blitzer JT, Pitcher JA, et al. (1998) The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 392: 626-630.
38. Jafri F, El-Shewy HM, Lee MH, Kelly M, Luttrell DK, et al. (2006) Expression of a chimeric neurokinin NK-1 receptor-beta-arrestin 1 fusion protein produces constitutive ERK1/2 activation in HEK-293 cells: Probing the composition and function of the G protein-coupled receptor 'signalsome'. J Biol Chem 281: 19346-19357.
39. Vaidehi N, Kenakin T, (2010) The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Curr Opin Pharmacol 10: 775-781.
40. Chadwick W, Magnus T, Martin B, Keselman A, Mattson MP, et al. (2008) Targeting TNF-alpha receptors for neurotherapeutics. Trends Neurosci 31 504-511, 2008.
41. Wootten D, Simms J, Koole C, Woodman OL, Summers RJ, et al. (2011) Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. J Pharmacol Exp Ther 336: 540-550.
42. Mallee JJ, Salvatore CA, LeBourdelles B, Oliver KR, Longmore J, et al. (2002) Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 277: 14294-14298.
43. Holloway AC, Qian H, Pipolo L, Ziogas J, Miura S, et al. (2002) Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization and phosphorylation of type 1A angiotensin receptors. Mol Pharmacol 61: 768-777.
44. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, et al. (2003) Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U SA 100: 11406-11411.
45. Gesty-Palmer D, Chen M, Oakley R, Ahn S, Nelson CD, et al. (2006) Distinct conformations of the parathyroid hormone receptor mediate G protein and beta-arrestin dependent activation of ERK1/2. J Biol Chem 281: 10856-10864.
46. Howlett AC, Blume LC, Dalton GD, (2010) CB(1) cannabinoid receptors and their associated proteins. Curr Med Chem 17: 1382-1393.
47. Webb TR, Clark AJ, (2010) The melanocortin 2 receptor accessory proteins. Mol Endocrinol 24: 475-484.
48. Della Rocca GJ, Maudsley S, Daaka Y, Lefkowitz RJ, Luttrell LM, (1999) Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J Biol Chem 274: 13978-13984.
49. Maudsley S, Zamah AM, Rahman N, Blitzer JT, Luttrell LM, et al. (2000) Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity. Mol Cell Biol 20: 8352-8363.
50. Chadwick W, Park SS, Zhou Y, Wang L, Brenneman R, et al. (2011) Repetitive peroxide exposure reveals pleiotropic mitogen-activated protein kinase signaling mechanisms. J Signal Transduct 2011 636951.